Short Decsription
Used for the blocking the cross-reactivity between anti-CHO HCP antibodies and monoclonal antibody drugs. Polyclonal antibody supplied at 1 mg/ml.
Description
Approximately one third of mAbs have cross-reactivity with anti-CHO HCP antibodies which can contribute to 20-80% of the HCP reading without blocking.